Suzuki Tomoaki, Asai Tohru, Matsubayashi Keiji, Kambara Atsushi, Ikegami Hirohisa, Kinoshita Takeshi, Nishimura Osamu
Department of Cardiovascular Surgery, Shiga University of Medical Science, Setatsukinowa, Ootsu, Shiga, Japan.
Gen Thorac Cardiovasc Surg. 2008 Jul;56(7):324-9. doi: 10.1007/s11748-008-0241-z. Epub 2008 Jul 8.
As there are few reports on the clinical results of off-pump coronary artery bypass (OPCAB) in patients with poor left ventricular (LV) function, the safety and efficacy of OPCAB surgery in such patients remains unclear.
From January 2002 to May 2007, a total of 519 consecutive patients underwent isolated myocardial revascularization via OPCAB. We compared the early and midterm results of 79 patients with poor LV function [ejection fraction (EF) < 40%] with those of 319 patients with normal LV function (EF >or= 50%). Follow-up was completed in 96.2% of the patients.
There were no significant intergroup differences in the number of grafts per patient or the rate of achievement of complete revascularization. No patient in either group was converted from off-pump to on-pump. The overall 30-day mortality was 1.0%. The mean follow-up was 3.0 +/- 1.3 years. Five-year freedom from death from all causes was 57.7% in the low-EF group and 83.6% in the normal-EF group. The rates of freedom from cardiac death were 73.2% and 93.7%, respectively; and the rates of freedom from the combined endpoint of cardiac death, myocardial infarction, repeat coronary intervention, and heart failure requiring treatment were 65.7% and 77.3%, respectively.
OPCAB surgery in patients with poor LV function can be performed safely with the same quality in terms of the number of grafts and rate of complete revascularization as in patients with normal LV function. There are higher mortality and cardiac event rates in patients with poor LV function than those with normal LV function at the midterm evaluation after OPCAB.
由于关于左心室(LV)功能不佳患者非体外循环冠状动脉搭桥术(OPCAB)临床结果的报道较少,此类患者行OPCAB手术的安全性和有效性仍不明确。
从2002年1月至2007年5月,共有519例连续患者通过OPCAB进行了单纯心肌血运重建。我们比较了79例LV功能不佳[射血分数(EF)<40%]患者与319例LV功能正常(EF≥50%)患者的早期和中期结果。96.2%的患者完成了随访。
每组患者的移植血管数量或完全血运重建率无显著组间差异。两组均无患者从非体外循环转为体外循环。总体30天死亡率为1.0%。平均随访时间为3.0±1.3年。低EF组全因死亡的5年生存率为57.7%,正常EF组为83.6%。心源性死亡的生存率分别为73.2%和93.7%;心源性死亡、心肌梗死、再次冠状动脉介入和需要治疗的心力衰竭这一联合终点的生存率分别为65.7%和77.3%。
LV功能不佳患者行OPCAB手术可以安全进行,在移植血管数量和完全血运重建率方面与LV功能正常患者具有相同的质量。在OPCAB术后中期评估中,LV功能不佳患者的死亡率和心脏事件发生率高于LV功能正常患者。